Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19

Condition:   Migraine Disorders Intervention:   Drug: Erenumab Sponsor:   Fayoum University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials